DSIP: The Delta Sleep-Inducing Peptide in Research

EXOMA Scientific Team · Publicado el 13 de abril de 2026 · Actualizado el 17 de agosto de 2026

DSIP (Delta Sleep Inducing Peptide): mechanism of action on delta waves, circadian regulation, evidence in insomnia and stress. Current research.

What is DSIP?

DSIP (Delta Sleep Inducing Peptide) is an endogenous 9-amino-acid neuropeptide discovered in 1977 by Schoenenberger and Monnier at the University of Basel, Switzerland. It was originally isolated from the cerebral venous blood of rabbits during electrically induced sleep.

Structure

• Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
• Molecular weight: 848.8 Da
• Amino acids: 9 residues
• N-terminal end: Tryptophan (free)
• C-terminal end: Glutamate (free)
• Endogenous localization: Hypothalamus, thalamus, cerebrospinal fluid, plasma

Distribution in the Body

DSIP has been identified in multiple compartments:

• Central nervous system: Hypothalamus, thalamus, brainstem
• Cerebrospinal fluid: Concentrations that vary with the circadian cycle
• Plasma: Present in peripheral circulation
• Adrenal gland: Local expression
• Gastrointestinal tract: Expression in enteroendocrine cells

Mechanisms of Action

DSIP exerts its effects through multiple neurotransmission systems:

1. Sleep Modulation

• Delta waves: Promotes slow-wave activity (0.5-4 Hz) on the EEG
• NREM sleep: Increases the proportion of slow-wave sleep (SWS)
• Sleep latency: Reduces the time needed to fall asleep
• Sleep architecture: Normalizes the distribution of sleep phases

2. Regulation of the HPA Axis

• ACTH: Modulates the secretion of adrenocorticotropic hormone
• Cortisol: Helps normalize the circadian rhythm of cortisol
• CRH: Interaction with corticotropin-releasing hormone
• Stress response: Modulating effect on the response to acute and chronic stress

3. Neuromodulatory Activity

4. Additional Properties

• Antioxidant: Protection against oxidative stress
• Thermoregulation: Modulation of body temperature during sleep
• Anticonvulsant: Protective effect in epilepsy models
• Analgesic: Modulation of pain perception

Scientific Evidence

Sleep Studies

EEG studies in humans (Schneider-Helmert, 1984):

• IV administration in patients with chronic insomnia
• Significant increase in slow-wave sleep
• Improvement in sleep efficiency
• No morning hangover effect
• No development of tolerance with repeated administration

Distinguishing features vs. conventional hypnotics:

• Does not produce forced sedation
• Does not alter REM architecture
• Does not cause dependence
• Promotes physiological, not pharmacological, sleep

Studies in Stress and Anxiety

• Reduction of stress markers in animal models
• Normalization of the circadian rhythm of cortisol
• Anxiolytic effects without daytime sedation
• Protection against the effects of chronic stress on sleep

Pain Studies

• Analgesic effect in acute and chronic pain models
• Potentiation of the effect of endogenous opioids (enkephalins)
• Modulation of central sensitization

Research on Withdrawal

Studies in alcohol and opioid withdrawal:

• Normalization of sleep patterns altered by withdrawal
• Reduction of anxiety associated with discontinuation
• Improvement in subjective sleep quality

Physiology of Slow-Wave Sleep

To understand the importance of DSIP, it is necessary to understand slow-wave sleep:

SWS Sleep Functions

1. Memory consolidation: Transfer of information from hippocampus to neocortex
2. GH secretion: 70% of daily growth hormone secretion occurs during SWS
3. Tissue restoration: Pico de actividad anabólica y reparadora
4. Glymphatic clearance: Brain drainage system most active during SWS
5. Immune regulation: Production of proinflammatory cytokines (IL-1, TNF-α) that mediate the immune response

Consequences of SWS Deficit

• Reduction of GH secretion
• Compromise of immune function
• Cognitive and memory impairment
• Increased pain sensitivity
• Alteration of carbohydrate metabolism

Pharmacokinetics

• Plasma half-life: ~15-25 minutes
• BBB penetration: Yes, via a specific transporter
• Metabolism: Degradation by plasma and tissue peptidases
• Circulating form: It exists both free and bound to transport proteins
• Circadian rhythm: Higher plasma levels during the night

Current State of Research

Active research areas with DSIP:

• Primary insomnia: Alternative to GABAergic hypnotics
• Circadian rhythm disorders: Jet lag, night work
• Chronic stress: Neuroendocrine protection
• Neurology: Neuroprotection and epilepsy
• Chronic pain: Modulation of central sensitization

Considerations for Research

• Reconstitution: Bacteriostatic water
• Storage: -20°C lyophilized, 2-8°C reconstituted
• Stability: Temperature-sensitive; avoid refreezing
• Administration in models: IV, SC or intranasal

Conclusion

DSIP represents a unique approach to sleep regulation: instead of forcing sedation like conventional hypnotics, it modulates the physiological mechanisms of slow-wave sleep. Its multimodal profile (sleep, stress, pain, neuroprotection) makes it a peptide of high interest for neuroscience research.

Available at Exoma Peptides with certificate of analysis included.

References

Material for research use only. Verified primary sources supporting the scientific claims of this article:

1. Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci U S A. 1977;74(3):1282-1286. doi:10.1073/pnas.74.3.1282. PMID 265572. (animal — conejo)
2. Schoenenberger GA, Maier PF, Tobler HJ, Wilson K, Monnier M. The delta EEG (sleep)-inducing peptide (DSIP). XI. Amino-acid analysis, sequence, synthesis and activity of the nonapeptide. Pflugers Arch. 1978;376(2):119-129. doi:10.1007/BF00581575. PMID 568769. (animal — conejo)
3. Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): an update. Peptides. 1986;7(6):1165-1187. doi:10.1016/0196-9781(86)90148-8. PMID 3550726. (revisión)
4. Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006;97(2):303-309. doi:10.1111/j.1471-4159.2006.03693.x. PMID 16539679. (revisión)
5. Tukhovskaya EA, Ismailova AM, Shaykhutdinova ER, et al. Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke. Molecules. 2021;26(17):5173. doi:10.3390/molecules26175173. PMID 34500605. (animal — rata)

Products available at EXOMA

• DSIP (Delta Sleep-Inducing Peptide)